The AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test is critical for diagnosing hereditary neurological disorders.this test utilizes advanced NGS technology to identify genetic mutations associated with spinocerebellar ataxia. It’s essential for individuals with a family history of neurological disorders, providing clarity and guidance for management and treatment options.
- Call Anytime: +254 704 150555
- info@biopassiondiagnostics.co.ke
AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test
Genetic Testing
AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test
KSh 56,000.00
Regular price
KSh 47,600.00
Current price
-15%
What Is the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test?
The AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant NGS Genetic DNA Test is a specialized genetic test designed to detect mutations in the AFG3L2 gene, which are associated with hereditary spinocerebellar ataxia type 28 (SCA28). This test is crucial for patients exhibiting symptoms related to this neurological disorder and can provide invaluable information for diagnosis and management.
Who Should Consider This Test?
The AFG3L2 Gene Spinocerebellar Ataxia Type 28 test is recommended for individuals who:
- Exhibit symptoms of spinocerebellar ataxia, such as balance issues, coordination problems, and difficulty with speech.
- Have a family history of neurological disorders, particularly those related to spinocerebellar ataxia.
- Are undergoing genetic counseling for hereditary conditions.
What Does the Test Detect or Measure?
This genetic test measures the presence of specific mutations in the AFG3L2 gene. By utilizing Next Generation Sequencing (NGS) technology, it offers a comprehensive analysis of the gene, allowing for accurate identification of genetic variations that may contribute to the development of spinocerebellar ataxia.
Test Preparation
This test requires a blood sample. Prior to testing, patients should undergo a genetic counseling session to discuss family history and draw a pedigree chart of affected family members.
What the Results May Show
Once the test is completed, results will be interpreted by a qualified genetic counselor or neurologist. They will provide guidance on the implications of your results, including potential health management strategies and family planning options.
Benefits or Clinical Value
Taking the AFG3L2 Gene test offers several benefits:
- Accurate Diagnosis: Helps in confirming a diagnosis of spinocerebellar ataxia type 28.
- Informed Decision-Making: Provides critical information for treatment planning and management.
- Family Planning: Assists families in understanding hereditary risks and making informed choices.
Pricing
| Test Name | Current Price | Regular Price |
|---|---|---|
| AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test | KSh 47,600.00 | KSh 56,000.00 |
Book the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test
Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.
SKU: 758be1f9f7a7 | Category: Genetic Testing